Cure Parkinson’s Research Update Meeting

Event Notes:

These research events offer Cure PD supporters the chance to meet funded researchers, who will present and discuss their ongoing projects. They also provide the opportunity to meet with members of the Parkinson’s community and the Cure Parkinson’s team in a relaxed setting.

Join in person or register to join the online livestream.

The Linked Clinical Trials (iLCT) programme aims to repurpose existing drugs that have shown promise in other diseases and test their effectiveness in people with Parkinson’s. Now in its 12th year, the iLCT initiative is the subject of this spring research update meeting focusing on advancements within the programme and featuring two key-note presentations: Professor Olivier Rascol will provide insights into the results from the phase 2 Lixipark study testing a diabetes drug, while Professor Per Svenningsson will present on the upcoming Montelukast phase 2 clinical trial testing an anti-inflammatory drug.